POSTER SESSION III Tuesday, March 25, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C HEMATOPATHOLOGY 122 Multiple Myeloma Oncogene 1 Protein (MUM1) Expression in Follicular Lymphomas (1089) H Kayano, T Hirose, T Mitsuhashi, M Shimizu Saitama Medical School, Iruma-gun, Saitama, Japan 123 Oct-2 and BOB.1/OBF.1 Expression in Surface Immunoglobulin Negative Follicular Lymphomas (1135) P Ramalingam, R Valdez, CW Ross, B Schnitzer, WG Finn University of Michigan, Ann Arbor, MI 124 Abnormal Expression of T-Cell Surface Antigens Detected by Flow Cytometry Can Frequently Identify Clonal T-Cell Expansions (1103) MR Lewis, L Hartung, J Greenwood, SL Perkins, DW Bahler University of Utah, Salt Lake City, UT 125 Flow Cytometric Diagnosis of Peripheral T-Cell Leukemias (TCLs) Using V$ Family Specific Antibodies (1031) R Beck, S Stahl, KS Theil, J Maciejewski, ED Hsi Cleveland Clinic, Cleveland, OH 126 Loss of Expression of Wnt/Beta-Catenin Signaling Pathway Transcription Factors LEF-1 and TCF-1 in a Subset of Peripheral T Cell Lymphomas (1053) DM Dorfman, H Greisman, A Shahsafaei Brigham and Women's Hospital and Harvard Medical School, Boston, MA 127 CD10 Expression in Nodal Peripheral T-Cell Lymphomas: A Feature Specific to Angioimmunoblastic T-Cell Lymphoma (1028) AD Attygalle, SS Chuang, TC Diss, PG Isaacson, MQ Du, A Dogan Royal Free and University College Medical School, London, United Kingdom 128 Diagnosis of T-Cell Lymphoma in Body Fluids: Cytological Features and Unusual Flow Cytometric Findings (1021) MG Abraham, M Balasubramanian, C Minimo, LM Galindo, JS Hou Drexel University College of Medicine, Philadelphia, PA 129 Variant Chromosomal Translocations in ALK Positive Anaplastic Large Cell Lymphoma of Pediatric Patients (1105) X Liang, L Odom, S Meech, MA Bitter, J Ryder, S Hunger, L Meltesen, R Hutchison, Q Wei, L McGavran University of Colorado Health Sciences Center, the Children's Hospital, Denver, CO 130 Suppressor of Cytokine Signaling-3 (SOCS-3) Expression in Anaplastic Large Cell Lymphoma (ALCL) (1137) GZ Rassidakis, P Tsioli, R Lai, AH Sarris, A Goy, F Gilles, LJ Medeiros University of Texas MD Anderson Cancer Center, Houston, TX 131 High Survivin Expression Correlates with ALK Expression and Null Cell Phenotype in Anaplastic Large Cell Lymphoma (1145) EJ Schlette, LJ Medeiros, R Lai, AH Sarris, TJ McDonnell, GZ Rassidakis University of Texas M.D. Anderson Cancer Center, Houston, TX 132 Overexpression of Insulin-Like Growth Factor Binding Protein 2 (IGFBP2) in Anaplastic Large Cell Lymphoma (1174) H Wang, GZ Rassidakis, H Wang, W Zhang, GN Fuller, LJ Medeiros University of Texas Medical School-Houston; M.D. Anderson Cancer Center, Houston, TX 133 Gene Expression Analysis in Karpas 299 Cells Treated with the Proteosome Inhibitor PS341 (1081) ED Hsi, X Zhao, E Mascha, G Lozanski, J Pettay, RR Tubbs, M Yegappan, TM Grogan, G Srkalovic Cleveland Clinic, Cleveland, OH; University of Texas Southwestern Medical Center, Dallas, TX; Ventana Medical Systems, Tucson, AZ 134 Clusterin, a Marker for Anaplastic Large Cell Lymphoma: Immunohistochemical Profile in Hematopoietic and Non-Hematopoietic Malignancies (1122) AF Nascimento, JL Pinkus, GS Pinkus Brigham & Women's Hospital & Harvard Medical School, Boston, MA 135 CD30-Positive T-Cell Lymphomas Co-Expressing CD15: An Immunohistochemical Analysis (1067) W Gorczyca, Z Liu, M Gangi, J Weisberger IMPATH Inc., New York City, NY 136 ALK-Positive Large B-Cell Lymphoma: A Report of Three Cases (1139) KK Reichard, RW McKenna, SH Kroft UT Southwestern Medical Center, Dallas, TX 137 Characterization of Rabbit Model for EBV-Associated Hemophagocytic Syndrome (HPS) (1074) K Hayashi, Z-S Jin, S Onoda, N Teramoto, N Ohara, W Oda, T Tanaka, TR Koirala, T Oka, T Yoshino, K Takahashi, T Akagi Okayama University Graduate School, Okayama, Japan 138 Limited Heterogeneity of Epstein-Barr Virus Subtypes and Sequences in EBV-Associate Malignant Lymphomas in Japanese Population (1127) N Ohara, K Hayashi, T Yoshino, T Akagi Okayama University, Okayama, Japan 139 Quantitative Assessment of EBV Infection in Lymphoid Tissues from Post-Transplant and Non-Transplant Patients from Columbia Presbyterian Hospital (CPH) (1149) R Shaknovich, F Rahmanon, G Cattoretti, B Alobeid Columbia University, New York, NY; Harlem Hospital, New York, NY 140 Histogenesis of Neoplastic B-Cells in Post-Transplant Lymphoproliferative Disorders (PTLD) Correlates with Transplantation Type and Site of Involvement (1123) L Novoa-Takara, B Kampalath, DH Vesole, V Shidham, A Rao, C Chang Medical College of Wisconsin, Milwaukee, WI 141 Post-Transplant Lymphoproliferative Disorder Following Non-Myeloablative Allogeneic Stem Cell Transplantation (1154) MJ Snyder, TT Stenzel, AS Lagoo, DA Rizzieri, N Chao, PJ Buckley, JZ Gong Duke University Medical Center, Durham, NC 142 Burkitt Lymphoma Arising in Organ Transplant Recipients: A Clinicopathologic Study of Five Cases (1065) JZ Gong, TT Stenzel, ER Bennett, AS Lagoo, CH Dunphy, PJ Buckley Duke University Medical Center, Durham, NC 143 Oral Cavity Lymphomas in AIDS Patients Are Strongly Associated with Human Herpes Virus Type 8 and EBV (1044) A Cioc, C Allen, J Kalmar, S Suster, G Nuovo Ohio State University, Columbus, OH 144 Plasmablastic Lymphoma (PL) in Non-Oral Sites: Immunophenotypic, Molecular and Cytogenetic Characterization of Three Cases (1027) SL Asplund, RW McKenna, Y-M Shen, SH Kroft University of Texas Southwestern Medical Center, Dallas, TX 145 Plasmablastic Lymphomas: Immunohistochemical Characteristics and In Situ Hibridization Analysis for EBV and HHV-8 Viruses (1121) MI Narbaitz, CA Martin, MDD Soler, S Sapia, U Zanetto Academia Nacional de Medicina, Buenos Aires; Hospital San Roque, Gonnet; Sanatorio Mater Dei, Buenos Aires; Laboratorio de Patologia, Mar del Plata, Argentina 146 Distinct Subsets of Primary Effusion Lymphoma Can Be Identified Based on Their Cellular Gene Expression Profile and Viral Association (1058) W Fan, D Bubman, A Chadburn, E Cesarman, DM Knowles Weill Medical College of Cornell University, New York, NY